drug
ixabepilone
Marketedupdated 3mo agoby R-Pharm US LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying ixabepilone
- phase2Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.
- phase2Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer
- phase2Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab
- phase2A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast Cancer
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that